BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 11099667)

  • 21. Fine mapping of the McLeod locus (XK) to a 150-380-kb region in Xp21.
    Ho MF; Monaco AP; Blonden LA; van Ommen GJ; Affara NA; Ferguson-Smith MA; Lehrach H
    Am J Hum Genet; 1992 Feb; 50(2):317-30. PubMed ID: 1734714
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The Kell blood group system: Kell and XK membrane proteins.
    Lee S; Russo D; Redman CM
    Semin Hematol; 2000 Apr; 37(2):113-21. PubMed ID: 10791880
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Kell phenotypes in 15 Japanese patients with chronic granulomatous disease.
    Ito K; Mukumoto Y; Konishi H; Sakura N; Usui T
    Vox Sang; 1979; 37(1):39-40. PubMed ID: 494579
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Haematological changes associated with the McLeod phenotype of the Kell blood group system.
    Wimer BM; Marsh WL; Taswell HF; Galey WR
    Br J Haematol; 1977 Jun; 36(2):219-24. PubMed ID: 871435
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Chronic granulomatous disease and the Mcleod phenotype. Successful treatment of infection with granulocyte transfusions resulting in subsequent hemolytic transfusion reaction.
    Brzica SM; Pineda AA; Taswell HF; Rhodes KH
    Mayo Clin Proc; 1977 Mar; 52(3):153-6. PubMed ID: 839862
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Localization of the McLeod locus (XK) within Xp21 by deletion analysis.
    Bertelson CJ; Pogo AO; Chaudhuri A; Marsh WL; Redman CM; Banerjee D; Symmans WA; Simon T; Frey D; Kunkel LM
    Am J Hum Genet; 1988 May; 42(5):703-11. PubMed ID: 3358422
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Auto analyzer determination of red cell Kell phenotypes in patients with chronic granulomatous disease (CGD) and heterozygous carriers.
    Bowell PJ; Hill FG
    Br J Haematol; 1978 Jul; 39(3):351-5. PubMed ID: 698113
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Kell and XK immunohistochemistry in McLeod myopathy.
    Jung HH; Russo D; Redman C; Brandner S
    Muscle Nerve; 2001 Oct; 24(10):1346-51. PubMed ID: 11562915
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Elevated serum creatine phosphokinase in subjects with McLeod syndrome.
    Marsh WL; Marsh NJ; Moore A; Symmans WA; Johnson CL; Redman CM
    Vox Sang; 1981; 40(6):403-11. PubMed ID: 7197431
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Chronic Granulomatous Disease with the McLeod Phenotype: a French National Retrospective Case Series.
    Lhomme F; Peyrard T; Babinet J; Abou-Chahla W; Durieu I; Moshous D; Neven B; Rohrlich PS; Albinni S; Amiranoff D; Dumont MD; Lortholary O; Héritier S; Marguet C; Suarez F; Fischer A; Blanche S; Hermine O; Mahlaoui N
    J Clin Immunol; 2020 Jul; 40(5):752-762. PubMed ID: 32562208
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A murine monoclonal antibody against Kx protein which reacts also with beta-spectrin.
    Carbonnet F; Blanchard D; Hattab C; Cochet S; Petit-Leroux Y; Loirat MJ; Cartron JP; Bertrand O
    Transfus Med; 2000 Jun; 10(2):145-54. PubMed ID: 10849386
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The first example of the McLeod phenotype in a Japanese baby with chronic granulomatous disease.
    Uchida K; Nakajima K; Shima H; Ichiba K
    Transfusion; 1992 Sep; 32(7):691. PubMed ID: 1519335
    [No Abstract]   [Full Text] [Related]  

  • 33. Human granulocytes lack red cell Kx antigen.
    Branch DR; Gaidulis L; Lazar GS
    Br J Haematol; 1986 Apr; 62(4):747-55. PubMed ID: 3516199
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The first example of autoanti-Kx.
    Sullivan CM; Kline WE; Rabin BI; Johnson CL; Marsh WL
    Transfusion; 1987; 27(4):322-4. PubMed ID: 2440157
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Chronic granulomatous disease and McLeod phenotype. Description of a case].
    Saggese G; Baroncelli GI; Bertelloni S; Gualtieri M; Carlotti C; Cinquanta L
    Minerva Pediatr; 1990 Apr; 42(4):151-6. PubMed ID: 2377152
    [TBL] [Abstract][Full Text] [Related]  

  • 36. An individual with McLeod syndrome and the Kell blood group antigen K(K1).
    Marsh WL; Schnipper EF; Johnson CL; Mueller KA; Schwartz SA
    Transfusion; 1983; 23(4):336-8. PubMed ID: 6879675
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Gene deletion in a patient with chronic granulomatous disease and McLeod syndrome: fine mapping of the Xk gene locus.
    Frey D; Mächler M; Seger R; Schmid W; Orkin SH
    Blood; 1988 Jan; 71(1):252-5. PubMed ID: 3334897
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Unmasking of Kx antigen by reduction of disulphide bonds on normal and McLeod red cells.
    Branch DR; Sy Siok Hian AL; Petz LD
    Br J Haematol; 1985 Mar; 59(3):505-12. PubMed ID: 2578808
    [TBL] [Abstract][Full Text] [Related]  

  • 39. McLeod syndrome resulting from a novel XK mutation.
    Singleton BK; Green CA; Renaud S; Fuhr P; Poole J; Daniels GL
    Br J Haematol; 2003 Aug; 122(4):682-5. PubMed ID: 12899725
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Insights into extensive deletions around the XK locus associated with McLeod phenotype and characterization of two novel cases.
    Peng J; Redman CM; Wu X; Song X; Walker RH; Westhoff CM; Lee S
    Gene; 2007 May; 392(1-2):142-50. PubMed ID: 17300882
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.